Title: 2025-2026 Regular Session HR 203 PN 1458 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1458
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 203 PN 1458 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1458 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.203 Session of 2025 INTRODUCED BY GUZMAN, HILL-EVANS, SANCHEZ, RIVERA AND CEPEDA-FREYTIZ, APRIL 22, 2025 REFERRED TO COMMITTEE ON HEALTH, APRIL 22, 2025 A RESOLUTIONDirecting the Joint State Government Commission to conduct a study of medication errors and issue a report to provide recommendations on reduction of errors and improved patient safety.WHEREAS, According to the National Coordinating Council for Medication Error Reporting and Prevention, medication errors are preventable mistakes made while prescribing or issuing medication to a patient; andWHEREAS, Medication errors can happen at any step in the process of prescribing medication, including when the medicine is prescribed, when the prescribed medication is entered into the computer system, when the medication is dispensed or when the medication is taken by an individual; andWHEREAS, Medication errors may have serious consequences such as death, hospitalization, disability or birth defects; andWHEREAS, Didier Epopa, a patient at Mercy Fitzgerald Hospital in Darby, Delaware County, was issued the wrong medication, which caused his body to seize and muscles to tighten; andWHEREAS, The error occurred because a pharmacy technician at 12345678910111213141516171819 Mercy Fitzgerald Hospital wrongly labeled the intravenous bag containing the medicine; andWHEREAS, A report on the medication error incident later found that the pharmacy technician was in fact not a technician, but rather a certified intern and should have been supervised; andWHEREAS, Under current State law, pharmacists are not required to notify the Pennsylvania Board of Pharmacy about medication errors, but instead must notify the prescribing doctor of a medication error within 24 hours of the error; andWHEREAS, Since pharmacists are not required to notify a State agency, many times this leads the hospital to only conduct an internal investigation of the error rather than involving the Department of Health; andWHEREAS, Hospitals are required to report "serious events," which are instances that result in death or serious harm to a patient, and "incidents," which are events that could have resulted in the death or serious harm to a patient, to the Pennsylvania Patient Safety Reporting System; andWHEREAS, According to the Pennsylvania Patient Safety Authority's 2022 Annual Report, there were 257,000 reports made, which included 247,000 reports regarding "incidents" and 10,000 reports regarding "serious events"; andWHEREAS, The United States Food and Drug Administration (FDA) has worked to reduce medication errors by reviewing medication names, packaging, labeling and directions for all medications and required barcodes to appear on some medications for the purpose of ensuring the correct strength and type of medication; andWHEREAS, The FDA also released a guidance in 2016 titled 20250HR0203PN1458 - 2 - 123456789101112131415161718192021222324252627282930 "Safety Considerations for Product Design to Minimize Medication Errors" to help reduce medication errors; andWHEREAS, Medication errors could be further reduced with the institution of adequate staff-to-patient ratios, so nurses and other health care professionals are not overwhelmed with a large number of patients and can provide better quality of care to patients; andWHEREAS, All Pennsylvanians would benefit from reduced occurrences of medication errors and improved patient safety; andWHEREAS, The House of Representatives should craft policy informed by a thorough understanding of how to reduce medication errors and improve patient safety; therefore be itRESOLVED, That the House of Representatives direct the Joint State Government Commission to conduct a study of medication errors and issue a report to provide recommendations on reduction of errors and improved patient safety; and be it furtherRESOLVED, That the study include how medication errors occur in different settings where patients are prescribed and administered medication, including acute care hospitals, rehabilitation centers, senior living centers, long-term care facilities and pharmacies; and be it furtherRESOLVED, That the Joint State Government Commission appoint an advisory committee to assist in this study; and be it furtherRESOLVED, That the advisory committee be composed of the following members:(1) The Secretary of Health or a designee.(2) One individual representing The Hospital and Healthsystem Association of Pennsylvania.20250HR0203PN1458 - 3 - 123456789101112131415161718192021222324252627282930 (3) One individual representing the Pennsylvania Medical Society.(4) One individual representing the Pennsylvania Pharmacists Association.(5) One individual representing Pennsylvania State Nurses Association.(6) One individual from the Pennsylvania Patient Advocacy Program within the Department of Health.(7) One licensed pharmacist to be selected by the Joint State Government Commission.(8) One licensed registered nurse to be selected by the Joint State Government Commission.(9) One licensed physician to be selected by the Joint State Government Commission.(10) Any other member identified as being helpful by the Joint State Government Commission;and be it furtherRESOLVED, That the study include policies adopted by other states to reduce medication errors; and be it furtherRESOLVED, That the study include best practices supported by stakeholders such as The Hospital and Healthsystem Association of Pennsylvania, the Pennsylvania Medical Society, the Pennsylvania Pharmacists Association and the Pennsylvania State Nurses Association; and be it furtherRESOLVED, That the study include a review of current Pennsylvania statute and regulations related to administration of medicine and reporting of medication errors; and be it furtherRESOLVED, That the study include a review of the agency in the Commonwealth with regulatory oversight of medication errors; 20250HR0203PN1458 - 4 - 123456789101112131415161718192021222324252627282930 and be it furtherRESOLVED, That the Joint State Government Commission present its report to the House of Representatives no later than 18 months after the adoption of this resolution.20250HR0203PN1458 - 5 - 1234


================================================================================

Raw Text:
2025-2026 Regular Session HR 203 PN 1458 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1458 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.203 Session of 2025 INTRODUCED BY GUZMAN, HILL-EVANS, SANCHEZ, RIVERA AND CEPEDA-FREYTIZ, APRIL 22, 2025 REFERRED TO COMMITTEE ON HEALTH, APRIL 22, 2025 A RESOLUTIONDirecting the Joint State Government Commission to conduct a study of medication errors and issue a report to provide recommendations on reduction of errors and improved patient safety.WHEREAS, According to the National Coordinating Council for Medication Error Reporting and Prevention, medication errors are preventable mistakes made while prescribing or issuing medication to a patient; andWHEREAS, Medication errors can happen at any step in the process of prescribing medication, including when the medicine is prescribed, when the prescribed medication is entered into the computer system, when the medication is dispensed or when the medication is taken by an individual; andWHEREAS, Medication errors may have serious consequences such as death, hospitalization, disability or birth defects; andWHEREAS, Didier Epopa, a patient at Mercy Fitzgerald Hospital in Darby, Delaware County, was issued the wrong medication, which caused his body to seize and muscles to tighten; andWHEREAS, The error occurred because a pharmacy technician at 12345678910111213141516171819 Mercy Fitzgerald Hospital wrongly labeled the intravenous bag containing the medicine; andWHEREAS, A report on the medication error incident later found that the pharmacy technician was in fact not a technician, but rather a certified intern and should have been supervised; andWHEREAS, Under current State law, pharmacists are not required to notify the Pennsylvania Board of Pharmacy about medication errors, but instead must notify the prescribing doctor of a medication error within 24 hours of the error; andWHEREAS, Since pharmacists are not required to notify a State agency, many times this leads the hospital to only conduct an internal investigation of the error rather than involving the Department of Health; andWHEREAS, Hospitals are required to report "serious events," which are instances that result in death or serious harm to a patient, and "incidents," which are events that could have resulted in the death or serious harm to a patient, to the Pennsylvania Patient Safety Reporting System; andWHEREAS, According to the Pennsylvania Patient Safety Authority's 2022 Annual Report, there were 257,000 reports made, which included 247,000 reports regarding "incidents" and 10,000 reports regarding "serious events"; andWHEREAS, The United States Food and Drug Administration (FDA) has worked to reduce medication errors by reviewing medication names, packaging, labeling and directions for all medications and required barcodes to appear on some medications for the purpose of ensuring the correct strength and type of medication; andWHEREAS, The FDA also released a guidance in 2016 titled 20250HR0203PN1458 - 2 - 123456789101112131415161718192021222324252627282930 "Safety Considerations for Product Design to Minimize Medication Errors" to help reduce medication errors; andWHEREAS, Medication errors could be further reduced with the institution of adequate staff-to-patient ratios, so nurses and other health care professionals are not overwhelmed with a large number of patients and can provide better quality of care to patients; andWHEREAS, All Pennsylvanians would benefit from reduced occurrences of medication errors and improved patient safety; andWHEREAS, The House of Representatives should craft policy informed by a thorough understanding of how to reduce medication errors and improve patient safety; therefore be itRESOLVED, That the House of Representatives direct the Joint State Government Commission to conduct a study of medication errors and issue a report to provide recommendations on reduction of errors and improved patient safety; and be it furtherRESOLVED, That the study include how medication errors occur in different settings where patients are prescribed and administered medication, including acute care hospitals, rehabilitation centers, senior living centers, long-term care facilities and pharmacies; and be it furtherRESOLVED, That the Joint State Government Commission appoint an advisory committee to assist in this study; and be it furtherRESOLVED, That the advisory committee be composed of the following members:(1) The Secretary of Health or a designee.(2) One individual representing The Hospital and Healthsystem Association of Pennsylvania.20250HR0203PN1458 - 3 - 123456789101112131415161718192021222324252627282930 (3) One individual representing the Pennsylvania Medical Society.(4) One individual representing the Pennsylvania Pharmacists Association.(5) One individual representing Pennsylvania State Nurses Association.(6) One individual from the Pennsylvania Patient Advocacy Program within the Department of Health.(7) One licensed pharmacist to be selected by the Joint State Government Commission.(8) One licensed registered nurse to be selected by the Joint State Government Commission.(9) One licensed physician to be selected by the Joint State Government Commission.(10) Any other member identified as being helpful by the Joint State Government Commission;and be it furtherRESOLVED, That the study include policies adopted by other states to reduce medication errors; and be it furtherRESOLVED, That the study include best practices supported by stakeholders such as The Hospital and Healthsystem Association of Pennsylvania, the Pennsylvania Medical Society, the Pennsylvania Pharmacists Association and the Pennsylvania State Nurses Association; and be it furtherRESOLVED, That the study include a review of current Pennsylvania statute and regulations related to administration of medicine and reporting of medication errors; and be it furtherRESOLVED, That the study include a review of the agency in the Commonwealth with regulatory oversight of medication errors; 20250HR0203PN1458 - 4 - 123456789101112131415161718192021222324252627282930 and be it furtherRESOLVED, That the Joint State Government Commission present its report to the House of Representatives no later than 18 months after the adoption of this resolution.20250HR0203PN1458 - 5 - 1234